Tradewinds LLC. Invests $509,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tradewinds LLC. bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 5,733 shares of the exchange traded fund’s stock, valued at approximately $509,000.

Several other institutional investors have also modified their holdings of XBI. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $29,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares during the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $38,000. Finally, Bank of Jackson Hole Trust acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $81.10 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $79.33 and a fifty-two week high of $105.47. The firm has a market capitalization of $5.26 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The stock has a 50 day moving average of $89.27 and a 200 day moving average of $93.78.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were given a dividend of $0.0053 per share. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.